Release date: February 2017
Valid through: February 2020
This activity is intended for hospitalists, intensivists and acute care clinicians.
- Fecal Transplant vs. Oral Vancomycin Taper for Recurrent Clostridium difficile Infection
- Bezlotoxumab Injection (Zinplava)
- Early Initiation of Continuous Renal Replacement Therapy May Reduce Mortality in Patients Who Require Dialysis
- Zika Virus Infection and Guillain-Barré Syndrome: The Evidence Grows
- Sacubitril/Valsartan Associated with Reduced Risk of Hyperkalemia
- Discuss pertinent safety, infection control and quality improvement practices;
- Explain diagnosis and treatment of acute illness in the hospital setting; and
- Discuss current data on diagnostic and therapeutic modalities for common inpatient problems.
- Maximum of 2.25 AMA PRA Category 1 Credits™
This activity is sponsored by AHC Media.
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Kenneth P. Steinberg, MD, Professor of Medicine, Program Director, Internal Medicine Residency Program, University of Washington
Physician Editor: Kenneth P. Steinberg, MD, Professor of Medicine, Program Director, Internal Medicine Residency Program, University of Washington
Peer Reviewer: Kevin Tompkins, MD, Pediatric Hospitalist, Mercy Children’s Hospital-St. Louis
Editor: Jill Drachenberg
Ebook Design Specialist: Dana Spector
Hospital Medicine Alert’s Physician Editor, Kenneth P. Steinberg, MD, Peer Reviewer Kevin M. Tompkins, MD, Editor Jill Drachenberg, and Ebook Design Specialist Dana Spector, have no relevant relationship related to the material presented in this issue.
Copyright 2017, AHC Media. All rights reserved.